Brief: Bellicum Pharmaceuticals Got Approval From Nasdaq to Transfer Listing Of Common Stock
17/06/2020 22:05
June 17 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS - ON JUNE 16, GOT APPROVAL FROM
NASDAQTO TRANSFER LISTING OF COMMON STOCK FROM NASDAQ GLOBAL
MARKET TO NASDAQ CAPITAL MARKET
* BELLICUM PHARMACEUTICALS - TRANSFER WILL BE EFFECTIVE AT
OPENING
OF BUSINESS ON JUNE 18
Source text: https://bit.ly/2YN6yGv
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview